These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
301 related articles for article (PubMed ID: 31250679)
1. Progress towards the development of Klebsiella vaccines. Choi M; Tennant SM; Simon R; Cross AS Expert Rev Vaccines; 2019 Jul; 18(7):681-691. PubMed ID: 31250679 [No Abstract] [Full Text] [Related]
2. Development of a broad spectrum glycoconjugate vaccine to prevent wound and disseminated infections with Klebsiella pneumoniae and Pseudomonas aeruginosa. Hegerle N; Choi M; Sinclair J; Amin MN; Ollivault-Shiflett M; Curtis B; Laufer RS; Shridhar S; Brammer J; Toapanta FR; Holder IA; Pasetti MF; Lees A; Tennant SM; Cross AS; Simon R PLoS One; 2018; 13(9):e0203143. PubMed ID: 30188914 [TBL] [Abstract][Full Text] [Related]
3. A promising bioconjugate vaccine against hypervirulent Feldman MF; Mayer Bridwell AE; Scott NE; Vinogradov E; McKee SR; Chavez SM; Twentyman J; Stallings CL; Rosen DA; Harding CM Proc Natl Acad Sci U S A; 2019 Sep; 116(37):18655-18663. PubMed ID: 31455739 [TBL] [Abstract][Full Text] [Related]
4. Vaccination with a trivalent Klebsiella pneumoniae vaccine confers protection in a murine model of pneumonia. Chen Z; Gou Q; Yuan Y; Zhang X; Zhao Z; Liao J; Zeng X; Jing H; Jiang S; Zhang W; Zeng H; Huang W; Zou Q; Zhang J Vaccine; 2024 Oct; 42(23):126217. PubMed ID: 39163713 [TBL] [Abstract][Full Text] [Related]
5. A Semi-Synthetic Glycoconjugate Vaccine Candidate for Carbapenem-Resistant Klebsiella pneumoniae. Seeberger PH; Pereira CL; Khan N; Xiao G; Diago-Navarro E; Reppe K; Opitz B; Fries BC; Witzenrath M Angew Chem Int Ed Engl; 2017 Nov; 56(45):13973-13978. PubMed ID: 28815890 [TBL] [Abstract][Full Text] [Related]
11. Seroepidemiology of Klebsiella bacteremic isolates and implications for vaccine development. Cryz SJ; Mortimer PM; Mansfield V; Germanier R J Clin Microbiol; 1986 Apr; 23(4):687-90. PubMed ID: 3517058 [TBL] [Abstract][Full Text] [Related]
12. Immunogenicity of a 24-valent Klebsiella capsular polysaccharide vaccine and an eight-valent Pseudomonas O-polysaccharide conjugate vaccine administered to victims of acute trauma. Campbell WN; Hendrix E; Cryz S; Cross AS Clin Infect Dis; 1996 Jul; 23(1):179-81. PubMed ID: 8816151 [TBL] [Abstract][Full Text] [Related]
13. Vaccination against 77 capsular types of Klebsiella aerogenes with polyvalent Klebsiella vaccines. Jones RJ; Roe EA J Med Microbiol; 1984 Dec; 18(3):413-21. PubMed ID: 6389878 [TBL] [Abstract][Full Text] [Related]
14. Re-evaluating the potential of immunoprophylaxis and/or immunotherapy for infections caused by multidrug resistant Klebsiella pneumoniae. Kobayashi SD; DeLeo FR Future Microbiol; 2018 Sep; 13(12):1343-1346. PubMed ID: 30256152 [No Abstract] [Full Text] [Related]
15. [Protective activity of a cell-free Klebsiella vaccine in relation to different Klebsiella pneumoniae serovars]. Kurbatova EA; Egorova NB; Kiseleva BS Zh Mikrobiol Epidemiol Immunobiol; 1984 Aug; (8):80-3. PubMed ID: 6385585 [TBL] [Abstract][Full Text] [Related]
16. Role of antibodies against outer-membrane proteins in murine resistance to infection with encapsulated Klebsiella pneumoniae. Serushago BA; Mitsuyama M; Handa T; Koga T; Nomoto K J Gen Microbiol; 1989 Aug; 135(8):2259-68. PubMed ID: 2699330 [TBL] [Abstract][Full Text] [Related]
17. Capsular Polysaccharide Types and Virulence-Related Traits of Epidemic KPC-Producing Klebsiella pneumoniae Isolates in a Chinese University Hospital. Liu Y; Liu PP; Wang LH; Wei DD; Wan LG; Zhang W Microb Drug Resist; 2017 Oct; 23(7):901-907. PubMed ID: 28437231 [TBL] [Abstract][Full Text] [Related]
18. [Effect of a hydroxylamine Klebsiella vaccine on the rate of elimination of the causative agent and on indices of humoral immunity]. Kurbatova EA; Lazareva ES; Gladus MA Zh Mikrobiol Epidemiol Immunobiol; 1988 Sep; (9):75-9. PubMed ID: 3061265 [TBL] [Abstract][Full Text] [Related]